RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Recommended For You
RemedyBio completes €10.5M financing from European Innovation Council
Remedy BiologicsJuly 20, 2021